Key facts
- Rhythm AI has appointed Mike Dineen as its new Chief Executive Officer.
- Dineen has over 30 years of experience in the MedTech industry.
- He will lead the company's U.S. clinical and commercial expansion.
Rhythm AI, a company specializing in atrial fibrillation (AF) procedures, has announced the appointment of Mike Dineen as its new Chief Executive Officer. Dineen, a seasoned executive with over three decades of experience in the medical technology sector, is expected to spearhead the company's growth initiatives in the United States, focusing on clinical development and commercialization efforts.